Skip to main content

Structure Therapeutics Inc.

GPCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001888886

No open-market purchases or sales by Structure Therapeutics Inc. insiders were filed in the last 90 days; 191 institutions reported holding it in 13F filings for Q2 2026, worth $3.62B in total; no superinvestor holds it.

Superinvestors holding GPCR, Q2 2026

See all superinvestors

No superinvestor reported holding GPCR in Q2 2026.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of GPCR each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q3 2024

    0 superinvestors holding at quarter end

    Sold out
    Duquesne Family Office
  2. Q2 2024

    1 superinvestor holding at quarter end

    New
    Duquesne Family Office